Increase within the cases of reflux sickness (GERD) because of excess acid production within the abdomen, like zollinger-ellison syndrome, might cause stomach ulcers or maybe abdomen cancer. Esomeprazole metallic element is employed throughout the beginning section of any reasonably excess acid issue within the abdomen to avoid any further serious consequences. These are a number of factors driving the world esomeprazole metallic element market.
Side-effects, like headache, diarrhoea, nausea or physiological reaction, constipation, abdomen pain or flatulence, may be a key issue restraining the world esomeprazole metallic element market. the majority WHO take esomeprazole seldom exhibit any side-effects. Side-effects square measure sometimes gentle and depart once the patient stops taking esomeprazole.
Prescription of esomeprazole metallic element in varied stomach-related issues that are caused because of acid reflux has created good chance for the world esomeprazole market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type,Application, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Alkem Laboratories Ltd.AstraZeneca plc.,Aurobindo Pharma Ltd.,Chongqing LUMMY Pharmaceutical Co., Ltd.,Dr. Reddy’s Laboratories Ltd.,Glenmark Pharmaceuticals Inc.,Grünenthal GmbH,Laboratorios Saval S.A.,Novartis AG (Sandoz),Sanofi SA,Stada Arzneimittel AG,Sun Pharmaceutical Industries Ltd.,Teva Pharmaceutical Industries Ltd. |
The covid-19 Impact on Esomeprazole Market:
Whereas, the chemicals and accouterments sectors were relatively affected during the pandemic. This is primarily due to uncut demand for chemicals for healthcare, life wisdom, and drawing agents. However, other elements of chemical and material sectors such as types of paints, industrial oil, construction materials are facing reduction in demand. Strict lockdown reflected in a nearly 50-60% reduction in force for raw supply and availability, which directly affected the manufacturing process. Further, halt on numerous end-use diligence directly affected the chemical demand each around the world.
Esomeprazole market Segment Overview
By Type, Capsules segment is predicted to grow at a major rate within the Esomeprazole market. In 2023, Zydus Cadila received a delayed-release U.S. fda (Food & Drug Administration) approval to manufacture and market esomeprazole metal delayed – release capsules. it's used to treat the symptoms of reflux sickness, to reduce the danger of abdomen ulcers in some people taking pain medicines, to treat patients with a stomach infection (Helicobacter pylori).
By Application, Gastroesophageal reflux disease(GERD) accounted major market share,Increase within the cases of gastroesophageal reflux disease (GERD) due to excess acid production within the stomach, like zollinger-ellison syndrome, could cause stomach ulcer or maybe stomach cancer. Esomeprazole sodium is employed throughout the beginning part of any reasonably excess acid issue within the stomach to avoid are serious consequences.
Market Analysis, Insights and Forecast – By Type
· Tablets
· Capsules
· Others
Market Analysis, Insights and Forecast – By Application
· Gastroesophageal Reflux Disease (GERD)
· Stomach Ulcers
· Others
Esomeprazole Market Regional Overview
Region-wise, in terms of regions ,North America held a significant share of the worldwide esomeprazole sodium market. stomach in lifestyle and food habits has been a significant explanation for problems associated with abdomen acid among people within the region. Europe is anticipated to follow North America in terms of share of the worldwide Esomeprazole metallic element market. Incidence or prevalence of many gastrointestinal disorders has increased drastically in various countries across Europe, that has any fuelled the demand for esomeprazole sodium.
Esomeprazole Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Esomeprazole Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Esomeprazole are highlighted below.
· In 2020, Cipla received a United States of America FDA (Food & Drug Administration) to manufacture the generic version of Nexium. it's used for treating GERD, zollinger-ellison syndrome, reducing the chance of NSAIDS associated gastric ulcers, and H.pylori eradication. Thus, the aforementioned factors area unit expected to spice up the market.
Esomeprazole Market, Key Players -
· Alkem Laboratories Ltd.
· AstraZeneca plc
· Aurobindo Pharma Ltd.
· Chongqing LUMMY Pharmaceutical Co., Ltd.
· Dr. Reddy’s Laboratories Ltd.
· Glenmark Pharmaceuticals Inc.
· Grünenthal GmbH
· Laboratorios Saval S.A.
· Novartis AG (Sandoz)
· Sanofi SA
· Stada Arzneimittel AG
· Sun Pharmaceutical Industries Ltd.
· Teva Pharmaceutical Industries Ltd.
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Esomeprazole Market during the forecast period?
Q2. Which segment is projected to hold the largest share in the Esomeprazole Market?
Q3. What are the driving factors for the Esomeprazole Market?
Q4. Which Segments are covered in the Esomeprazole Market report?
Q5. Which are the prominent players offering Esomeprazole Market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Esomeprazole Market analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. •Tablets
- 5.2.2. •Capsules
- 5.2.3. •Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Gastroesophageal Reflux Disease (GERD)
- 5.3.2. •Stomach Ulcers
- 5.3.3. •Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. •Tablets
- 6.2.2. •Capsules
- 6.2.3. •Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Gastroesophageal Reflux Disease (GERD)
- 6.3.2. •Stomach Ulcers
- 6.3.3. •Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. UK
- 6.4.2. Germany
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Rest of Europe
7. Asia Pacific Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. •Tablets
- 7.2.2. •Capsules
- 7.2.3. •Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Gastroesophageal Reflux Disease (GERD)
- 7.3.2. •Stomach Ulcers
- 7.3.3. •Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. China
- 7.4.2. India
- 7.4.3. Japan
- 7.4.4. Australia
- 7.4.5. South East Asia
- 7.4.6. Rest of Asia Pacific
8. Latin America, Middle East, and Africa Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. •Tablets
- 8.2.2. •Capsules
- 8.2.3. •Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Gastroesophageal Reflux Disease (GERD)
- 8.3.2. •Stomach Ulcers
- 8.3.3. •Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. Brazil
- 8.4.2. Saudi Arabia
- 8.4.3. UAE
- 8.4.4. Rest of LAMEA
9. Competitive Analysis
- 9.1. Company Market Share Analysis, 2018
- 9.2. Key Industry Developments
- 9.3. Company Profile
- 9.4. Alkem Laboratories Ltd.
- 9.4.1. Business Overview
- 9.4.2. Segment 1 & Service Offering
- 9.4.3. Overall Revenue
- 9.4.4. Geographic Presence
- 9.4.5. Recent Development
- 9.5. •AstraZeneca plc
- 9.6. •Aurobindo Pharma Ltd.
- 9.7. •Chongqing LUMMY Pharmaceutical Co., Ltd.
- 9.8. •Dr. Reddy’s Laboratories Ltd.
- 9.9. •Glenmark Pharmaceuticals Inc.
- 9.10. •Grünenthal GmbH
- 9.11. •Laboratorios Saval S.A.
- 9.12. •Novartis AG (Sandoz)
- 9.13. •Sanofi SA
- 9.14. •Stada Arzneimittel AG
- 9.15. •Sun Pharmaceutical Industries Ltd.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
